AstraZeneca FluMist / Fluenz (influenza vaccine) by Year

Name: AstraZeneca FluMist / Fluenz (influenza vaccine) by Year (AZN)
Creator: AstraZeneca

FluMist / Fluenz (influenza vaccine) — Worldwide product sales ($M) ($M)

Quarterly Annual

AstraZeneca FluMist / Fluenz (influenza vaccine): $272M in FY2025, up 5.4% from a year earlier.

Latest, FY2025

272

Period ended Dec 31, 2025

Change on a year earlier

+5.4%

258 in FY2024

History

10 years

Since FY2016

Sources

Documents cited below

Where the FY2025 figure comes from

“|| FluMist | 272 | 6 | 3 | 28 | 1 | 5 | n/m | n/m | 210 | 3 | (1) | 29 | 19 | 19”

Source: Form 6-K FY2025Q4 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	FluMist / Fluenz (influenza vaccine) — Worldwide product sales ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	272	+5.4%	Form 6-K FY2025Q4 Earnings Release ↗
FY2024	Dec 31, 2024	258	+19.4%	Form 6-K FY2024Q4 Earnings Release ↗
FY2023	Dec 31, 2023	216	+23.4%	Form 6-K FY2023Q4 Earnings Release ↗
FY2022	Dec 31, 2022	175	-30.8%	Form 6-K FY2022Q4 Earnings Release ↗
FY2021	Dec 31, 2021	253	-14.2%	Form 6-K FY2021Q4 Earnings Release ↗
FY2020	Dec 31, 2020	295	+161.1%	Form 6-K FY2020Q4 Earnings Release ↗
FY2019	Dec 31, 2019	113	+2.7%	Form 20-F (filed 2022-02-22) ↗
FY2018	Dec 31, 2018	110	+41.0%	Form 20-F (filed 2019-03-05) ↗
FY2017	Dec 31, 2017	78	-25.0%	Form 20-F (filed 2019-03-05) ↗
FY2016	Dec 31, 2016	104	–	Form 20-F (filed 2019-03-05) ↗

Breakdown

What makes up fluMist / Fluenz (influenza vaccine)

Cite this data

StockData. (2026). AstraZeneca FluMist / Fluenz (influenza vaccine) ($M), annual FY2016–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-flumist-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.